Revolutionizing Diabetes Treatment: Alpha Cells as Natural GLP-1 Producers

New research reveals pancreatic alpha cells can naturally produce GLP-1, a hormone that boosts insulin and may transform type 2 diabetes treatment by leveraging the body's own hormone production mechanisms.
Recent research from Duke University School of Medicine has challenged traditional views on blood sugar regulation by revealing an unexpected function of pancreatic alpha cells. Previously thought to only produce glucagon—a hormone involved in raising blood sugar during fasting or exercise—these cells are now found to also generate GLP-1, a potent hormone that enhances insulin release and helps regulate glucose levels. Using advanced mass spectrometry techniques, scientists discovered that human alpha cells naturally produce higher levels of bioactive GLP-1 than previously recognized, and this production is directly linked to insulin secretion.
Led by Dr. Jonathan Campbell, the research team examined pancreatic tissues from humans and mice across various ages, weights, and diabetic conditions. Their findings suggest that alpha cells are more adaptable, capable of adjusting hormone output to support beta cells and maintain blood sugar homeostasis. Notably, when glucagon production was blocked in mouse models, alpha cells increased GLP-1 produção, which improved glucose control and stimulated greater insulin release—indicating that GLP-1 can compensate when glucagon synthesis is inhibited.
This discovery has significant implications for diabetes treatment. Although GLP-1 is mainly produced in the gut, this study confirms pancreatic alpha cells can also secrete this hormone into the bloodstream after eating, contributing to blood sugar regulation. Mild metabolic challenges, such as high-fat diets, can modestly boost GLP-1 production from alpha cells, opening new avenues for therapies that aim to enhance the body's natural hormone production. The research team developed a precise mass spectrometry assay to measure bioactive GLP-1 accurately, which may facilitate future studies on boosting GLP-1 levels.
Dr. Campbell emphasizes that these findings suggest the body has a built-in contingency plan: in times of metabolic stress, alpha cells switch from producing glucagon to generating GLP-1, providing a natural mechanism to support insulin secretion and maintain glucose balance. This hormone shift could pave the way for innovative diabetes treatments that harness the body's own cells to produce GLP-1, potentially offering more natural and effective management of blood sugar levels.
Source: https://medicalxpress.com/news/2025-09-alpha-cells-moonlight-secret-glp.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Finds No Survival Benefit in Reducing Oxygen for Critically Ill Patients
New UK-ROX trial reveals that reducing supplemental oxygen in ICU patients is safe but offers no significant survival advantage, emphasizing the need for personalized oxygen therapy strategies.
Angola Reports Over 20,000 Cholera Cases Since January Amid Outbreak
Angola reports over 20,000 cholera cases with more than 600 fatalities since January, highlighting ongoing public health challenges due to poor sanitation and water safety.
Research Indicates Semen Quality May Reveal Broader Men's Health Risks
New research suggests semen analysis may serve as an early indicator of men's overall health, linking reproductive parameters to long-term health risks and lifestyle factors.
Enhancing Rural Manufacturing Innovation as a Strategy to Reduce the US Trade Deficit
Emerging research suggests that investing in innovation and infrastructure in rural America could unlock significant export potential, helping to reduce the US trade deficit and promote regional economic growth.



